KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Change in Acquisitions & Divestments (2016 - 2025)

Biogen has reported Change in Acquisitions & Divestments over the past 17 years, most recently at -$33.6 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at -$33.6 million for Q4 2025, up 65.25% from a year ago — trailing twelve months through Dec 2025 was $23.0 million (changed N/A YoY), and the annual figure for FY2025 was $23.0 million, changed.
  • Change in Acquisitions & Divestments for Q4 2025 was -$33.6 million at Biogen, down from $56.6 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for BIIB hit a ceiling of $7.3 billion in Q4 2023 and a floor of -$1.6 billion in Q3 2023.
  • Median Change in Acquisitions & Divestments over the past 5 years was $486.5 million (2022), compared with a mean of $990.1 million.
  • Peak annual rise in Change in Acquisitions & Divestments hit 1184.58% in 2023, while the deepest fall reached 195.91% in 2023.
  • Biogen's Change in Acquisitions & Divestments stood at $3.3 billion in 2021, then tumbled by 82.91% to $566.3 million in 2022, then surged by 1184.58% to $7.3 billion in 2023, then plummeted by 101.33% to -$96.7 million in 2024, then surged by 65.25% to -$33.6 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were -$33.6 million (Q4 2025), $56.6 million (Q3 2025), and -$96.7 million (Q4 2024) per Business Quant data.